SPY AGENT GREEN LYMPHATICS KIT FOR ADVANCED IMAGING MODALITY (AIM) AND PINPOINT

Страна: Канада

Язык: английский

Источник: Health Canada

Активный ингредиент:

INDOCYANINE GREEN

Доступна с:

NOVADAQ TECHNOLOGIES ULC

код АТС:

V04CX01

ИНН (Международная Имя):

INDOCYANINE GREEN

дозировка:

25MG

Фармацевтическая форма:

KIT

состав:

INDOCYANINE GREEN 25MG

Администрация маршрут:

INTERSTITIAL

Штук в упаковке:

15G/50G

Тип рецепта:

Ethical

Терапевтические области:

ROENTGENOGRAPHY

Обзор продуктов:

Active ingredient group (AIG) number: 0150962001; AHFS:

Статус Авторизация:

APPROVED

Дата Авторизация:

2020-05-01

Характеристики продукта

SPY AGENT™ GREEN
Indocyanine Green for Injection, USP
25 mg/vial
Lyophilized powder for intravenous or interstitial injection
Fluorescent Imaging Agent
Novadaq Technologies ULC. (now a part of Stryker)
8329 Eastlake Drive, Unit 101
Burnaby, British Columbia
V5A 4W2
Date of Draft:
November 28, 2018
Date of Initial Approval:
Date of Revision:
Submission Control No: 213662
Page 2 of 20
TABLE OF CONTENTS
TABLE OF CONTENTS
..............................................................................................................2
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................4
1
INDICATIONS
..................................................................................................................4
1.1
Pediatrics
...............................................................................................................4
1.2
Geriatrics
...............................................................................................................4
2
CONTRAINDICATIONS
.................................................................................................4
3
DOSAGE AND ADMINISTRATION
.............................................................................5
3.1
Dosing Considerations
..........................................................................................5
3.2
Recommended Dose and Dosage Adjustment
......................................................5
3.3
Administration
......................................................................................................5
3.4
Reconstitution
.......................................................................................................6
3.5
Missed Dose
..........................................................................................................7
4
OVERDOSAGE
.................................................................................................................7
5
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ................8
6
WARNINGS AN